P3 Health Partners Stock EBITDA

PIIIW Stock

USD 0.01 0 21.17%

P3 Health Partners fundamentals help investors to digest information that contributes to P3 Health's financial success or failures. It also enables traders to predict the movement of PIIIW Stock. The fundamental analysis module provides a way to measure P3 Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to P3 Health stock.

		Last Reported	Projected for Next Year
	EBITDA	-81.1 M	-85.1 M

EBITDA is likely to drop to about (85.1 M) in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

P3 Health Partners Company EBITDA Analysis

P3 Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current P3 Health EBITDA

(81.07 M)

Most of P3 Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, P3 Health Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

PIIIW EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for P3 Health is extremely important. It helps to project a fair market value of PIIIW Stock properly, considering its historical fundamentals such as EBITDA. Since P3 Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of P3 Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of P3 Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Intangible Assets
Total Assets		0.93	-0.73	0.17	-0.29	0.93	0.76	0.59	0.82	0.76	0.95	0.75	0.93	-0.85	-0.39	0.88	-0.85	-0.38
Total Stockholder Equity	0.93		-0.57	0.04	-0.2	0.77	0.65	0.53	0.72	0.66	0.95	0.71	0.91	-0.74	-0.26	0.68	-0.74	-0.35
Current Deferred Revenue	-0.73	-0.57		-0.65	0.7	-0.9	-0.93	-0.87	-0.85	-0.9	-0.76	-0.64	-0.86	0.83	0.72	-0.91	0.83	0.67
Net Debt	0.17	0.04	-0.65		-0.98	0.33	0.72	0.81	0.7	0.73	0.32	0.63	0.38	-0.65	-0.96	0.54	-0.65	-0.89
Retained Earnings	-0.29	-0.2	0.7	-0.98		-0.41	-0.8	-0.88	-0.79	-0.81	-0.46	-0.73	-0.51	0.74	0.98	-0.6	0.74	0.93
Accounts Payable	0.93	0.77	-0.9	0.33	-0.41		0.83	0.66	0.82	0.8	0.86	0.64	0.91	-0.83	-0.48	0.95	-0.83	-0.44
Long Term Debt	0.76	0.65	-0.93	0.72	-0.8	0.83		0.96	0.95	1.0	0.85	0.82	0.89	-0.94	-0.84	0.92	-0.94	-0.74
Net Receivables	0.59	0.53	-0.87	0.81	-0.88	0.66	0.96		0.89	0.97	0.75	0.77	0.8	-0.86	-0.88	0.77	-0.86	-0.8
Good Will	0.82	0.72	-0.85	0.7	-0.79	0.82	0.95	0.89		0.96	0.88	0.94	0.89	-0.99	-0.84	0.91	-0.99	-0.82
Total Liab	0.76	0.66	-0.9	0.73	-0.81	0.8	1.0	0.97	0.96		0.86	0.85	0.88	-0.95	-0.85	0.9	-0.95	-0.75
Net Invested Capital	0.95	0.95	-0.76	0.32	-0.46	0.86	0.85	0.75	0.88	0.86		0.83	0.98	-0.9	-0.52	0.84	-0.9	-0.53
Short Long Term Debt	0.75	0.71	-0.64	0.63	-0.73	0.64	0.82	0.77	0.94	0.85	0.83		0.78	-0.95	-0.8	0.77	-0.95	-0.8
Total Current Assets	0.93	0.91	-0.86	0.38	-0.51	0.91	0.89	0.8	0.89	0.88	0.98	0.78		-0.89	-0.55	0.87	-0.89	-0.57
Capital Stock	-0.85	-0.74	0.83	-0.65	0.74	-0.83	-0.94	-0.86	-0.99	-0.95	-0.9	-0.95	-0.89		0.82	-0.93	1.0	0.76
Net Working Capital	-0.39	-0.26	0.72	-0.96	0.98	-0.48	-0.84	-0.88	-0.84	-0.85	-0.52	-0.8	-0.55	0.82		-0.69	0.82	0.9
Short Term Debt	0.88	0.68	-0.91	0.54	-0.6	0.95	0.92	0.77	0.91	0.9	0.84	0.77	0.87	-0.93	-0.69		-0.93	-0.58
Common Stock	-0.85	-0.74	0.83	-0.65	0.74	-0.83	-0.94	-0.86	-0.99	-0.95	-0.9	-0.95	-0.89	1.0	0.82	-0.93		0.76
Intangible Assets	-0.38	-0.35	0.67	-0.89	0.93	-0.44	-0.74	-0.8	-0.82	-0.75	-0.53	-0.8	-0.57	0.76	0.9	-0.58	0.76

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict P3 Health

Ebitda Over Time

PIIIW Ebitda

Ebitda

(85.12 Million)

P3 Health reported EBITDA of (81.07 Million) in 2023

According to the company disclosure, P3 Health Partners reported earnings before interest,tax, depreciation and amortization of (81.07 Million). This is 109.24% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 102.08% higher than that of the company.

PIIIW EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses P3 Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of P3 Health could also be used in its relative valuation, which is a method of valuing P3 Health by comparing valuation metrics of similar companies.

P3 Health is currently under evaluation in ebitda category among its peers.

PIIIW Fundamentals

	Return On Equity	-0.41
	Return On Asset	-0.12
	Profit Margin	(0.05) %
	Operating Margin	(0.08) %
	Number Of Shares Shorted	34.02 K
	Revenue	1.27 B
	EBITDA	(81.07 M)
	Net Income	(57.77 M)
	Cash And Equivalents	4.34 M
	Cash Per Share	0.10 X
	Total Debt	121.94 M
	Current Ratio	0.45 X
	Book Value Per Share	1.22 X
	Cash Flow From Operations	(76.03 M)
	Earnings Per Share	(1.34) X
	Number Of Employees	400
	Beta	1.14
	Total Asset	860.97 M
	Retained Earnings	(367.34 M)
	Working Capital	(133.35 M)
	Net Asset	860.97 M

About P3 Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze P3 Health Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of P3 Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of P3 Health Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for PIIIW Stock Analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC